Abstract
Allograft Vasculopathy In article number 2106786, Sanjiv Dhingra and co-workers demonstrate the development and application of immunoengineered tantalum-carbide MXene quantum dots (MQDs) for the treatment of transplant vasculopathy. These MQDs are synthesized with high efficiency and purity using a hydrofluoric acid-free protocol and are enriched with bioactive functional groups. The MQDs possess intrinsic immunomodulatory properties, are spontaneously uptaken into antigen-presenting cells, and reduce activation of allogeneic T-lymphocytes.
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
